Human DNA methylation profiles have been used successfully to develop highly accurate biomarkers of aging (“epigenetic clocks”). Although these human epigenetic clocks are not immediately applicable to all species of the animal kingdom, the principles underpinning them appear to be conserved even in animals that are evolutionarily far removed from humans. This is exemplified by recent development of epigenetic clocks for mice and other mammalian species. Here, we describe epigenetic clocks for the domestic cat (Felis catus), based on methylation profiles of CpGs with flanking DNA sequences that are highly conserved between multiple mammalian species. Methylation levels of these CpGs are measured using a custom-designed Infinium array (HorvathMammalMethylChip40). From these, we present 3 epigenetic clocks for cats; of which, one applies only to blood samples from cats, while the remaining two dual-species human-cat clocks apply both to cats and humans. We demonstrate that these domestic cat clocks also lead to high age correlations in cheetahs, tigers, and lions. It is expected that these epigenetic clocks for cats possess the potential to be further developed for monitoring feline health as well as being used for identifying and validating anti-aging interventions.
Most owners of domestic cats lament the short lifespan of these widely popular pets. The maximum (confirmed) lifespan of cats is 30 years according to the animal age data base (anAge) [1, 2] but most cats succumb to diseases before they are 20 years old . Age is undoubtedly the biggest risk factor for a vast majority of diseases in animals, and cats are no exception. Interventions to slow aging are being sought. Ideally, testing should occur in species that are evolutionarily close to humans, similar in size, have high genetic diversity, and share the same environment as humans. It has been recognized that domestic dogs fulfill these criteria [4,5,6]. These investigations, however, have yet to be extended to cats since these pets share similar environments and living conditions with their human owners as well. Identification of environmental factors and living conditions that affect aging, as well as potential mitigation measures, can be achieved by proxy, with cats. A pre-requisite for such investigations, however, is a highly accurate set of biomarkers of aging for both, cats, and humans. While there is a rich literature on human epigenetic clocks for various individual and multiple tissues [7,8,9,10], we are not aware of any existing epigenetic clocks for cats. The human epigenetic clocks have already found many biomedical applications including the measure of biological age in human anti-aging clinical trials [7, 11]. This has instigated the development of similar clocks for other mammals such as mice and dogs [12,13,14,15,16,17,18]. Here, we aimed to develop and evaluate epigenetic clocks for cats, as such biomarkers are necessary for translating promising anti-aging interventions from humans to cats and vice versa, and to also provide the possibility of using the epigenetic aging rate of cats to inform on feline health; for which, a quantitative measure is presently unavailable. Specifically, we present here DNA methylation-based biomarkers (epigenetic clocks) of age for blood from cats.
It was known for a long while that the degree of cellular DNA methylation alters with age [19,20,21]. The significance and specificity of these alterations remained a source of speculation until the development of an array-based technology that permitted the simultaneous quantification of methylation levels of specific CpG positions on the human genome. With technical advancement came the opportunity and insight to combine age-related methylation changes of multiple DNA loci to develop a highly accurate age estimator for all human tissues [7, 8, 10]. For example, the human pan-tissue clock combines the weighted average of methylation levels of 353 CpGs into an age estimate that is referred to as DNAm age or epigenetic age . As would be expected of such an age estimator, its prediction of epigenetic age corresponds closely to chronological age. What is significantly more important, however, is the finding that the discrepancy between epigenetic age and chronological age (which is termed “epigenetic age acceleration”) is predictive of multiple health conditions, even after adjusting for a variety of known risk factors [23,24,25,26,27,28]. Specifically, epigenetic age acceleration is associated with but not limited to cognitive and physical functioning , Alzheimer’s disease , centenarian status [27, 31], Down syndrome , progeria [33, 34], HIV infection , Huntington’s disease , obesity , and menopause . Epigenetic age is also predictive of mortality even after adjusting for known risk factors such as age, sex, smoking status, and other risk factors [23,24,25,26,27,28]. Collectively, the evidence is compelling that epigenetic age is an indicator of biological age [39,40,41].
We previously demonstrated that the human pan-tissue clock, which was trained with only human DNA methylation profiles, can be applied directly to chimpanzees , but it loses utility for other animals as a results of evolutionary genome sequence divergence. Recently, others have constructed epigenetic clocks for mice and successfully validated them with benchmark longevity interventions including calorie restriction and growth hormone receptor knockouts [12,13,14,15,16,17]. Most murine epigenetic clocks for chronological age have not yet been evaluated with respect to their predictive utility for mortality risk in mice. However, methylation-based predictors of life expectancy have been developed for mice .
Overall, these independent initiatives indicate that the underlying biological principle of epigenetic clocks is shared between members of different species within the mammalian class, and that it is possible and feasible to extend the development of epigenetic clocks to other mammalian species. Our current study primary pursued the goal of developing a DNA methylation-based estimator of chronological age across the entire lifespan of cats and humans (dual-species clocks). To evaluate whether human-cat dual species also apply to other species, we evaluated them in other cat species (cheetahs, tigers, and lions) and non-cat species of the mammalian class: guinea pigs, rabbits, ferrets, and alpacas. Finally, we characterize age-related changes in methylation levels in cats to identify genomic regions that gain/lose methylation with age.
We generated DNA methylation profiles from n = 130 blood samples from cats of different breeds, whose ages ranged from 0.21 to 20.9 years (Tables 1 and 2). Cat breeds did not correspond to distinct clusters in the unsupervised hierarchical clustering analysis (color band in Fig. 1). This suggests that most CpGs on the mammalian array do not differ between cat breeds. Most of the blood samples were from neutered cats: 50 from neutered females, 51 from neutered males, 9 from intact females, and 19 from intact males. Their DNA methylation profiles clustered by sex (Fig. 1). One of the cat samples was removed from the analysis because its sex did not match the clustering pattern.
A subsequent random forest analysis of sex led to perfect (out-of-bag, OOB) estimates of accuracy (zero misclassifications). Neutered status was strongly confounded with age: 25 out of 28 intact animals were younger than 0.8 years. A random forest prediction analysis of neutered status led to a high OOB error rate (> 60% error rate) when restricting the analysis to the young samples.
To study to what extent tour dual-species clocks generalize to other species, we also generated blood DNA methylation profiles from non-domestic cat species (n = 14 cheetahs, n = 5 lions, n = 7 tigers) and more distant mammalian species: n = 2 guinea pigs, n = 5 rabbits, n = 2 ferrets, and n = 5 alpacas (Table 1). As would be expected, the methylation profiles of these were clearly clustered by species (Supplementary Figure S1).
We developed three epigenetic clocks for cats that vary with regards to two features: species and measure of age. The basic cat clock, which is constituted by 34 CpGs, was trained on cat blood DNA methylation profiles, while the dual-species (human-cat) epigenetic clocks were trained using cat and human DNA methylation data. The resulting two human-cat clocks mutually differ by way of age measurement. One estimates chronological ages of cats and humans (in units of years) based on methylation profiles of 563 CpG, while the other employs the methylation profiles of 540 CpGs to estimate relative age, which is the ratio of chronological age of an animal to the maximum lifespan of its species, with resulting values between 0 and 1. This relative age ratio is highly advantageous because it allows alignment and biologically meaningful comparison between species with very different lifespans such as cat and human, which cannot otherwise be afforded by direct comparison of their chronological ages.
To arrive at unbiased estimates of the epigenetic clocks, we carried out cross-validation analysis of the training data. To develop the basic cat clock, the training data employed consisted of cat blood DNA methylation profiles, while human and cat DNA methylation profiles constituted the training data for both the human-cat clocks. The cross-validation study reports unbiased estimates of the age correlation R (defined as Pearson correlation between the age estimate—DNAm age—and chronological age), as well as the median absolute error. As indicated by its name, the cat blood clock is highly accurate in age estimation of blood (R = 0.97 and median absolute error 0.83 years, Fig. 2A). The human-cat clock for chronological age is highly accurate when DNA methylation profiles of both species are analyzed together (R = 0.98, Fig. 2B), and remains remarkably accurate when restricted to cat blood samples (R = 0.97, Fig. 2C). Similarly, the human-cat clock for relative age exhibits high correlation regardless of whether the analysis is applied to samples from both species (R = 0.98, Fig. 2D) or only to cat samples (R = 0.97, Fig. 2E). This demonstrates that relative age circumvents the skewing that is inherent when chronological age of species with very different lifespans is measured using a single formula.
A cross-validation analysis reveals that both human-cat clocks lead to highly accurate estimates in human blood and skin samples (R ≥ 0.96, Supplementary Figure S2).
Application to 3 other cat species
To study whether the domestic cat clocks generalize to other cat species, we applied these clocks to blood samples from cheetahs (Acinonyx jubatus), lions (Panthera leo nubica), and tigers (Panthera tigris).
All 3 cat domestic clocks lead to high correlations between age and its DNA methylation age estimate in blood samples from cheetahs (r ≥ 0.85, Fig. 3A–C), D-F) lions (r ≥ 0.98, Fig. 3D–F), and tigers (r > 0.97, Fig. 3G–I). A high correlation coefficient indicates that these cat clocks can be used to rank-order blood samples from these non-domestic species with respect to age. However, the domestic cat clocks are poorly calibrated and exhibit a systematic offset as indicated by high median absolute errors in these different species. The domestic cat clock outperforms the human-cat clock when it comes to the median absolute error, e.g., in lions, MAE = 1.4 years for the pure cat clock and MAE = 11.6 years for the human-cat clock of age (Fig. 3D, E). A similar discrepancy can be observed in tigers: MAE = 3.0 years for the pure cat clock and MAE = 8.9 years for the human-cat clock (Fig. 3G, H).
In total, 34,851 probes from HorvathMammalMethylChip40 are aligned to loci that are proximal to 5379 genes in Felis_catus_9.0.100 genome assembly. Due to the high inter-species conservation of the probes on the array, findings from the cat methylation data can probably be extrapolated to human and other mammalian species. Epigenome-wide association analysis of chronological age revealed a very significant impact of age on DNAm changes (Fig. 4A). The methylation level of 1379 CpGs altered in function of age, with a significance of p < 10−8. The CpGs with the greatest methylation changes and the corresponding proximal genes are as follows: SLC12A5 promoter (correlation test Z statistic z = 20), HECTD2 exon (z = − 17), hypermethylation in 8 CpGs in NEUROD1 promoter (z = 8.3 to 16.7), and hypermethylation in two CpGs in FOXG1 intron (z = 8.9 to 16.4), and 5 CpGs in FOXG1 exon (z = 8.5 to 11.1, Fig. 4A). Aging-associated CpGs were distributed in genic, as well as intergenic regions that can be defined relative to transcriptional start sites (Fig. 4B). In promoters and 5′UTRs, 76% of CpGs increased methylation with age.
These regions are primarily composed of CpG islands, which corroborates with our subsequent analysis demonstrating that CpG islands have higher positive correlation with age compared to other CpG sites (Fig. 4C).
Transcriptional factor enrichment analysis suggests that hypomethylation in SP1 and hypermethylation in PAX4 binding sites are among the top motifs that show age-associated changes in cat blood (Fig. 4D).
Gene-level enrichment analysis of the significant CpGs highlighted changes in transcription factor activity, development, nervous system changes, and also pathways related to diabetes onset, which all overlap with aging biology in humans and other species (Fig. 4E). Several potential upstream regulators were also identified as discussed below.
We further examined the enrichment of tissue type-specific epigenome states for DNAm aging in cats. In both chromatin state analysis and histone 3 marks, the top tissue type predicted for both hypermethylated and hypomethylated CpGs was blood, which is as it should be, as this is indeed the tissue from which the cat DNA was derived (Supplementary Figure S3). The age-associated hypomethylated CpGs were primarily flanking active transcriptional start sites (TSS) and enhancer regions. These CpGs are also marked with H3K4me1 and H3K4me3 modifications which are associated with active transcription. In contrast, age-associated hypermethylation occurs mainly in bivalent/poised TSS, flanking bivalent TSS/Enhancer, bivalent enhancer, and repressed Polycomb binding sites. The histone marks for hypermethylated CpGs included H3K27me27, H3K4me1, and H3K9me3. Collectively, these are all consistent with repression of gene expression from these sites. DNaseI hypersensitive marks (DHS) did not identify blood as our target tissue type, suggesting that age-related DNA methylation changes in nucleosome-depleted (open chromatin) sites are probably not tissue-specific.
Applying the cat clocks to other species
Having developed these three cat clocks, we used them to estimate the ages of blood DNA methylation profiles from four other mammalian species: guinea pigs, rabbits, ferrets, and alpacas (Fig. 5). It was not expected that these clocks would estimate their ages accurately. Instead, this was carried out to ascertain the degree by which these cat clocks can predict the age of animals within a non-cat species, relative to each other, as indicated by a high correlation coefficient between age and DNAmAge. Understandably, the cat clock and the human-cat clock, which operate with chronological age, registered estimates that are very distant from the chronological age of the animals. Despite this, these two clocks correctly predicted the ages of these animals relative to each other (within the same species). This was similarly observed with the second dual-species clock, the human-cat relative age clock. It is acknowledged that the paucity of samples, especially of guinea pig and ferret, necessitate some caution in interpretation, but collectively, these results are consistent with the fact that epigenetic clocks developed for one mammalian species can be employed to a limited extent, to other species, and reveal the association of DNA methylation changes with age.
We have previously developed several human epigenetic clocks from DNA methylation profiles that were derived from various versions of human Illumina DNA methylation arrays. As these arrays are specific to the human genome, a critical step toward crossing the species barrier was the use of a mammalian DNA methylation array that profiles up to 36 thousand CpGs with flanking DNA sequence that are highly conserved across numerous mammalian species. The employment of this array to profile 128 blood samples represents the most comprehensive epigenetic dataset of domestic cats thus far. These data allowed us to construct highly accurate DNA methylation-based age estimators for the domestic cat that is applicable to their entire life course (from birth to old age). The successful derivation of a cat clock using CpGs that are embedded within evolutionarily conserved DNA sequences across the mammalian class further confirms the conservation of the biological mechanism that underpins aging. The ability of the cat clocks to correctly predict ages of animals of the same species (guinea pigs, rabbits, ferrets, and alpacas), relative to each other goes a little further in support of this notion. While the mechanism of epigenetic aging remains to be identified and described, its presence in a host of mammalian species and possibly beyond indicates an ancient provenance. The potential that the cat clock would contribute to feline health is encouraged by the fact that human epigenetic age acceleration is associated with a wide array of primary traits, health states, and pathologies. While it is still unclear why age acceleration is connected to these characteristics, it does nevertheless suggest that extension of similar studies to cats may allow for the development of epigenetic age acceleration as a surrogate or indicator of feline biological fitness.
An equally important potential of the cat clock is the feasibility of including domestic cats in aging research. Domestic cats share the same living environment as their human owners, but with a lifespan that is considerably shorter. This allows not only investigation into age-affecting factors and potential mitigators of aging, but also the impact of these on longevity, which is not readily carried out with humans. However, to accurately translate age-related findings from cats to humans requires a correct and accurate measure of age-equivalence. The present rule of thumb where a 1-year-old cat is equivalent to a 15-year-old human, and a 2-year-old cat is equivalent to a 24-year-old human, followed by the addition of 4 years to ever year of a cats life from then on, is a very crude approximation.
We fulfilled this need through a two-step process. First, we combined DNA methylation profiles of cats and humans to generate a dual-species clock (human-cat), which is as accurate in estimating cat age as it is for human age; in chronological unit of years. This demonstrates the feasibility of building epigenetic clocks for different species based on a single mathematical formula. That this single formula is equally applicable to both species effectively demonstrates that epigenetic aging mechanisms are highly conserved. However, the incorporation of two species with very different maximum lifespans, such as cat and human, into a single representative graph, raises the inevitable challenge of polarized distribution of data points along the age range. Furthermore, this does not resolve the challenge of age-equivalence between these two species. We addressed these two challenges simultaneously by expressing the ages of every cat and human in respect to the maximum recorded ages of their respective species (species lifespan), i.e., 30 years for cats and 122 years for humans [1, 2]. The mathematical operation of generating a ratio eliminates chronological unit of time and produces a value that indicates the age of the organism in respect to the maximum age of its own species. This allows a meaningful and realistic cross-species comparison of biological age. For example, the biological fitness of a 20 year-old cat, which is very old, is not equivalent to that of a 20-year-old human, who is young. However, a cat with a relative epigenetic age of 0.5 is more comparable to a human of similar relative epigenetic age. Collectively, the ability to use a single mathematical formula to measure epigenetic age of different species and the replacement of chronological unit of time with proportion of lifespan are two significant innovations that will propel cross-species research as well as cross-species benefits. A comparison between dog and human methylomes revealed a nonlinear relationship that translates dog-to-human years and aligns the timing of major physiological milestones between the two species . Our dual-species clock for relative age does not assume a nonlinear relationship between different species.
Detailed analyses of age-related methylation changes in cat blood reveals that CpGs that became increasingly methylated with age are located largely within promoters, CpG islands, and exons. On the other hand, CpGs that become de-methylated with age are most often found to reside in introns. The consequence of DNA methylation, especially within CpG islands and promoters, is largely suppression of transcription. However, the outcome of intron demethylation is less easy to generalize. Much can be speculated about how these methylation changes can coordinate expression of genes proximal (or perhaps distal too) to these CpGs in function of age. With the lack of precise understanding notwithstanding, these epigenetic changes are nevertheless consistent with, and likely mediate, the widely observed age-related changes in gene expression.
Transcriptional factor enrichment analysis suggests that hypomethylation in SP1 and hypermethylation in PAX4 binding sites are among the top motifs that show age-associated changes in cat blood (Fig. 4D).
In principle, this would indicate greater access of SP1 protein to some of its binding sites, with increasing age. However, the outcome of this is difficult to predict as SP1 activates the transcription of many genes that are involved in diverse cellular processes ranging from cell growth, apoptosis, and immune response to chromatin remodeling. However, the collective enrichment of gene targets of four of the transcription factors together (SMAD3, SP1, SP3, and E2F1) points to their involvement in telomerase regulation (enrichment p = 3e − 9). In addition, SP1 and E2F1 target genes are also involved in mitophagy (enrichment p = 2e − 4). The involvement of both telomerase and mitophagy in aging is well-attested in the literature . PAX4 on the other hand is a transcription factor whose target genes are involved in differentiation and development, likewise, with TFAP2.
In the absence of empirical data on age-related gene expression changes in cats, we identified genes that are in proximity to age-related CpGs, and then went on to ascertain the intracellular pathways, or diseases/conditions that are associated with these genes. Unsurprisingly, these did not produce results that were immediately obvious and easily understood as being the cause of aging. Indeed, as our understanding of aging is at its infancy, separating the cause from the consequence of these age-related changes is a formidable endeavor. Instead, what these results provide is an early glimpse into potential pathways that should be further investigated and tested to ascertain how and why their alterations accompany increasing age. In this regard, it is noteworthy that pathways involved in organism development and maintenance of organ and tissue function constitute a significant portion of the top pathways identified. This contrasts with cancers for example, where alterations to expression of oncogenes, tumor suppressor genes, and DNA repair proteins and checkpoints proteins are often encountered. In other words, age-related changes appear to involve development and maintenance of cell function and identity, rather than cellular proliferation or repair. This is consistent with the high score of age-related methylation changes to targets of PAX4 and TFAP2 transcription factors, whose target genes participate in differentiation and development. This is further typified by the fact that the target loci of PRC2, Suz12, and histone H3K27me3 are identified as being hypermethylated with age. Suz12 is a component of PRC2, which methylates histone H3K27, which in turn binds to chromatin to prevent transcription of genes that are primarily involved in cell commitment, cellular differentiation, and maintenance of cell identity. Interestingly, Suz12 and histone 3K27me3 targets are similarly modified with age, in dogs . Indeed, such age-related methylation was also previously identified in humans, to occur disproportionately at CpGs in PRC2 target sites , reinforcing the importance of the process of development in aging and cross-species conservation of the aging process. This is further supported by the fact that hypermethylation of bivalent chromatin domain, PRC-binding sites, and H3K27me3 featured very strongly with age-related feline CpGs that were analyzed with eForge version 2 . Cross-species concordance of transcription factors, chromatin states, genes, and pathways that score highly in computational analyses of age-associated CpGs is a very effective way to identify the most relevant ones from a large number of hits. In this regard, TFAP2, ZFP161, and E2F1/3 are proteins whose binding sites on DNA become increasingly methylated with age in cats as well as bats (manuscript submitted separately). The fact that these far-removed species exhibit these similarities encourages greater attention to be paid to these proteins and their functions. As mentioned above, TFAP2 is a transcription factor whose target genes are involved in the cellular differentiation and organ development. ZFP161 protein binds to GC-rich DNA regions, regulates DNA replication fork stability, and maintains genomic stability . It is interesting that another genomic stabilizing protein, the retinoblastoma protein (RB), exerts it effect through binding the E2F transcription factor [47, 48], whose binding sites become increasingly methylated with age in these two species. This is particularly relevant as genomic instability is a hallmark of cancers  as well as aging . The relationship between these two biological conditions has long been recognized, and their co-appearance in these studies consolidate this relationship and suggest potential common mechanisms that await elucidation. Moreover, the identification of age-associated methylation changes to targets of transcriptional factors that regulate telomerase expression and mitophagy also speaks to the likelihood of this connection. It is notable that regulation of telomerase, mitophagy, genomic instability, and epigenetics are implicated in feline aging, as these are four of the nine identified hallmarks of aging .
This article is primarily concerned with domestic cats. We acknowledge that our studies of other cat species and non-cat species suffer from low sample sizes. We present this material since the estimates of correlation coefficients may inform the design of future studies. Our epigenetic clocks for cats have not yet been validated against actual clinically relevant outcomes such as mortality and disease risk. This critical assessment needs to be done before these clocks can be considered as applicable measure of biological aging.
We expect that future interventional studies in cats will complement studies in companion dogs. Anti-aging interventions that are beneficial in two different companion pet species are arguably more promising than those that work only in a single species. As epigenetic clocks for increasing number of mammals are developed and become available, it will be highly informative to ascertain whether the age-related features (development and genomic instability), identified in cats and other mammals thus far, would continue to emerge. The emerging picture thus far consolidates the notion that understanding of aging in mammals such as cats, who intimately share our living environment, can be translated to human aging. In the mammalian methylation array, the dual-species (human-cat) clocks are innovations that will greatly assist in this endeavor.
Materials and methods
Feline and other animal blood samples
The DNA archive of the Royal Veterinary College (RVC) was searched for feline ethylenediaminetetraacetic acid (EDTA) blood samples that were residuals from previous routine hematology testing. Cats were selected to represent the widest age range possible based on the available samples with a uniform distribution across the entire range, available breeds, and neutering status. As the samples originated from cats that were presented for veterinary investigation, cats were selected to have no or minimal abnormalities on available laboratory data (hematology, serum biochemistry, endocrinology), reviewed by a board certified veterinary clinical pathologists (BSz). The DNA samples were maintained frozen at − 80 °C for various amount of time (0–11 years). Samples from guinea pigs, rabbits, ferrets, and alpacas were also residual samples from routine patients presented for veterinary care. Sample collection was approved by the Clinical Research Ethical Review Board of the RVC (URN: 2019 1947–2). Genomic DNA from cat blood was extracted using the Zymo DNA extraction kit according to the manufacturer’s instructions. DNA was eluted in water and quantified with picogreen kit according to the instructions provided.
Non-domestic cat species
Blood samples from cheetah (Latin name Acinonyx jubatus), lion (Panthera leo nubica), and tiger (Panthera tigris) were opportunistically collected and banked during routine health exams from these zoo-based animals located at Busch Gardens and White Oak Conservation. These samples are described in Table 1.
Human tissue samples
To build the human-cat clock, we analyzed previously generated methylation data from n = 1211 human tissue samples (adipose, blood, bone marrow, dermis, epidermis, heart, keratinocytes, fibroblasts, kidney, liver, lung, lymph node, muscle, pituitary, skin, spleen) from individuals whose ages ranged from 0 to 93. The tissue samples came from three sources. Tissue and organ samples are from the National NeuroAIDS Tissue Consortium . Blood samples from the Cape Town Adolescent Antiretroviral Cohort study . Skin and other primary cells are provided by Kenneth Raj . Ethics approval is as follows: IRB#15–001,454, IRB#16–000,471, IRB#18–000,315, IRB#16–002,028.
DNA methylation data
All methylation data were generated with the custom Infinium array “HorvathMammalMethylChip40” . The mammalian methylation array provides high coverage (over thousand-fold) of highly conserved CpGs in mammals. Out of 37,492 CpGs on the array, 35,988 probes were chosen to assess cytosine DNA methylation levels in mammalian species . The particular subset of species for each probe is provided in the chip manifest file. The SeSaMe normalization method was used to define beta values for each probe .
Penalized regression models
Details on the clocks (CpGs, genome coordinates) and R software code are provided in the Supplement.
Penalized regression models were created with glmnet . We investigated models produced by both “elastic net” regression (alpha = 0.5). The optimal penalty parameters in all cases were determined automatically by using a tenfold internal cross validation (cv.glmnet) on the training set. By definition, the alpha value for the elastic net regression was set to 0.5 (midpoint between Ridge and Lasso type regression) and was not optimized for model performance.
We performed a cross-validation scheme for arriving at unbiased (or at least less biased) estimates of the accuracy of the different DNAm-based age estimators. One type consisted of leaving out a single sample (LOOCV) from the regression, predicting an age for that sample, and iterating over all samples. A critical step is the transformation of chronological age (the dependent variable). While no transformation was used for the blood clock for cats, we did use a log linear transformation for the dual-species clock of chronological age (Supplement). Coefficient values and CpGs underlying the clocks can be found in the Supplementary Material.
Relative age estimation
To introduce biological meaning into age estimates of cats and humans that have very different lifespan; as well as to overcome the inevitable skewing due to unequal distribution of data points from cats and humans across age range, relative age estimation was made using the formula: Relative age = Age/maxLifespan where the maximum lifespan for the two species was chosen from the anAge data base .
Epigenome-wide association studies of age
EWAS was performed in each tissue separately using the R function “standardScreeningNumericTrait” from the “WGCNA” R package . Next, the results were combined across tissues using Stouffer’s meta-analysis method.
The data will be made publicly available as part of the data release from the Mammalian Methylation Consortium. Genome annotations of these CpGs can be found on Github https://github.com/shorvath/MammalianMethylationConsortium.
de Magalhaes JP, Costa J, Church GM. “An analysis of the relationship between metabolism, developmental schedules, and longevity using phylogenetic independent contrasts,” (in eng). J Gerontol A Biol Sci Med Sci. 2007;62(2):149–60.
J. P. de Magalhaes, J. Costa, and O. Toussaint, "HAGR: the human ageing genomic resources," Nucleic Acids Res, vol. 33, no. Database issue, pp. D537–43, Jan 1 2005, https://doi.org/10.1093/nar/gki017.
D. G. O’Neill, D. B. Church, P. D. McGreevy, P. C. Thomson, and D. C. Brodbelt. Longevity and mortality of cats attending primary care veterinary practices in England. Journal of Feline Medicine and Surgery, vol. 17, no. 2, pp. 125–133, 2015/02/01 2014, https://doi.org/10.1177/1098612X14536176.
M. Kaeberlein, K. E. Creevy, and D. E. L. Promislow. The dog aging project: translational geroscience in companion animals. Mamm Genome, vol. 27, no. 7, pp. 279–288, 2016// 2016, https://doi.org/10.1007/s00335-016-9638-7.
Gilmore KM, Greer KA. “Why is the dog an ideal model for aging research?,” (in eng). Exp Gerontol. 2015;71:14–20. https://doi.org/10.1016/j.exger.2015.08.008.
J. J. Hayward et al., "Complex disease and phenotype mapping in the domestic dog," Nature Communications, vol. 7, no. 1, p. 10460, 2016/01/22 2016, https://doi.org/10.1038/ncomms10460.
S. Horvath and K. Raj, "DNA methylation-based biomarkers and the epigenetic clock theory of ageing," (in eng), Nat Rev Genet, Apr 11 2018, https://doi.org/10.1038/s41576-018-0004-3.
Field AE, Robertson NA, Wang T, Havas A, Ideker T, Adams PD. “DNA methylation clocks in aging: categories, causes, and consequences,” (in eng). Mol Cell. 2018;71(6):882–95. https://doi.org/10.1016/j.molcel.2018.08.008.
K. Raj and S. Horvath. Current perspectives on the cellular and molecular features of epigenetic ageing. Exp Biol Med, p. 1535370220918329, 2020, https://doi.org/10.1177/1535370220918329.
C. G. Bell et al. DNA methylation aging clocks: challenges and recommendations. Genome Biology, vol. 20, no. 1, p. 249, 2019/11/25 2019, https://doi.org/10.1186/s13059-019-1824-y.
Fahy GM, et al. Reversal of epigenetic aging and immunosenescent trends in humans. Aging Cell. 2019;18(6): e13028. https://doi.org/10.1111/acel.13028.
D. A. Petkovich, D. I. Podolskiy, A. V. Lobanov, S. G. Lee, R. A. Miller, and V. N. Gladyshev, "Using DNA methylation profiling to evaluate biological age and longevity interventions," (in eng), Cell Metab, vol. 25, no. 4, pp. 954–960 e6, Apr 4 2017, https://doi.org/10.1016/j.cmet.2017.03.016.
J. J. Cole et al., "Diverse interventions that extend mouse lifespan suppress shared age-associated epigenetic changes at critical gene regulatory regions," (in eng), Genome Biol, vol. 18, no. 1, p. 58, Mar 28 2017. https://doi.org/10.1186/s13059-017-1185-3.
T. Wang et al., "Epigenetic aging signatures in mice livers are slowed by dwarfism, calorie restriction and rapamycin treatment," (in eng), Genome Biol, vol. 18, no. 1, p. 57, Mar 28 2017, https://doi.org/10.1186/s13059-017-1186-2.
T. M. Stubbs et al., "Multi-tissue DNA methylation age predictor in mouse," Genome Biol, vol. 18, no. 1, p. 68, Apr 11 2017, https://doi.org/10.1186/s13059-017-1203-5.
Thompson MJ, et al. “A multi-tissue full lifespan epigenetic clock for mice,” (in eng). Aging (Albany NY). 2018;10(10):2832–54. https://doi.org/10.18632/aging.101590.
M. V. Meer, D. I. Podolskiy, A. Tyshkovskiy, and V. N. Gladyshev. A whole lifespan mouse multi-tissue DNA methylation clock. eLife, vol. 7, p. e40675, 2018/11/14 2018, https://doi.org/10.7554/eLife.40675.
M. J. Thompson, B. vonHoldt, S. Horvath, and M. Pellegrini. An epigenetic aging clock for dogs and wolves. Aging (Albany NY), vol. 9, no. 3, pp. 1055–1068, 03/26 02/06/received 03/18/accepted 2017, https://doi.org/10.18632/aging.101211.
V. K. Rakyan et al. Human aging-associated DNA hypermethylation occurs preferentially at bivalent chromatin domains, (in eng), Genome Res, Research Support, Non-U.S. Gov’t vol. 20, no. 4, pp. 434–9, Apr 2010, https://doi.org/10.1101/gr.103101.109.
Teschendorff AE, et al. “Age-dependent DNA methylation of genes that are suppressed in stem cells is a hallmark of cancer,” (in eng). Genome Res. 2010;20(4):440–6. https://doi.org/10.1101/gr.103606.109.
J.-P. Issa Aging and epigenetic drift: a vicious cycle. J Clin Invest, vol. 124, no. 1, pp. 24–29, 2014
Horvath S. “DNA methylation age of human tissues and cell types,” (in eng). Genome Biol. 2013;14(10):R115. https://doi.org/10.1186/gb-2013-14-10-r115.
R. Marioni et al. DNA methylation age of blood predicts all-cause mortality in later life. Genome Biol., vol. 16, no. 1, p. 25, 2015. [Online]. Available: http://genomebiology.com/2015/16/1/25.
Christiansen L, et al. “DNA methylation age is associated with mortality in a longitudinal Danish twin study,” (in eng). Aging Cell. 2016;15(1):149–54. https://doi.org/10.1111/acel.12421.
Perna L, Zhang Y, Mons U, Holleczek B, Saum KU, Brenner H. Epigenetic age acceleration predicts cancer, cardiovascular, and all-cause mortality in a German case cohort. Clin Epigenetics. 2016;8:64. https://doi.org/10.1186/s13148-016-0228-z.
Chen BH, et al. “DNA methylation-based measures of biological age: meta-analysis predicting time to death,” (in Eng). Aging (Albany NY). 2016;8(9):1844–65. https://doi.org/10.18632/aging.101020.
Horvath S, et al. “Decreased epigenetic age of PBMCs from Italian semi-supercentenarians and their offspring,” (in eng). Aging (Albany NY). 2015;7(12):1159–70. https://doi.org/10.18632/aging.100861.
Lu AT, et al. “DNA methylation GrimAge strongly predicts lifespan and healthspan,” (in eng). Aging (Albany NY). 2019;11(2):303–27. https://doi.org/10.18632/aging.101684.
R. Marioni, S. Shah, A. F. McRae, S. J. Ritchie, and G. Muniz-Terrera. The epigenetic clock is correlated with physical and cognitive fitness in the Lothian Birth Cohort 1936. Int J Epidemiol, vol. 44, 2015, https://doi.org/10.1093/ije/dyu277
Levine ME, Lu AT, Bennett DA, Horvath S. “Epigenetic age of the pre-frontal cortex is associated with neuritic plaques, amyloid load, and Alzheimer’s disease related cognitive functioning,” (in eng). Aging (Albany NY). 2015;7(12):1198–211. https://doi.org/10.18632/aging.100864.
Horvath S, et al. “The cerebellum ages slowly according to the epigenetic clock,” (in eng). Aging (Albany NY). 2015;7(5):294–306.
S. Horvath et al. Accelerated epigenetic aging in Down syndrome. Aging Cell, vol. 14, no. 1, 2015. https://doi.org/10.1111/acel.12325.
S. Horvath, J. Oshima, G. Martin, K. Raj, and S. Matsuyama. Epigenetic age estimator for skin and blood applied to Hutchinson Gilford Progeria, 2018.
Maierhofer A, Flunkert J, Oshima J, Martin GM, Haaf T, Horvath S. “Accelerated epigenetic aging in Werner syndrome,” (in eng). Aging (Albany NY). 2017;9(4):1143–52. https://doi.org/10.18632/aging.101217.
Horvath S, Levine AJ. “HIV-1 infection accelerates age according to the epigenetic clock,” (in eng). J Infect Dis. 2015;212(10):1563–73. https://doi.org/10.1093/infdis/jiv277.
Horvath S, et al. “Huntington’s disease accelerates epigenetic aging of human brain and disrupts DNA methylation levels,” (in eng). Aging (Albany NY). 2016;8(7):1485–512. https://doi.org/10.18632/aging.101005.
Horvath S, et al. Obesity accelerates epigenetic aging of human liver. Proc Natl Acad Sci U S A. 2014;111(43):15538–43. https://doi.org/10.1073/pnas.1412759111.
Levine ME, et al. “Menopause accelerates biological aging,” (in eng). Proc Natl Acad Sci U S A. 2016;113(33):9327–32. https://doi.org/10.1073/pnas.1604558113.
Jylhava J, Pedersen NL, Hagg S. Biological age predictors. EBioMedicine. 2017;21:29–36. https://doi.org/10.1016/j.ebiom.2017.03.046.
X. Li et al. Longitudinal trajectories, correlations and mortality associations of nine biological ages across 20-years follow-up, (in eng), eLife, vol. 9, p. e51507, 2020, https://doi.org/10.7554/eLife.51507.
Ferrucci L, et al. Measuring biological aging in humans: A quest. Aging Cell. 2020;19(2): e13080. https://doi.org/10.1111/acel.13080.
M. B. Schultz et al., "Age and life expectancy clocks based on machine learning analysis of mouse frailty," Nature Communications, vol. 11, no. 1, p. 4618, 2020/09/15 2020. https://doi.org/10.1038/s41467-020-18446-0.
T. Wang et al., Quantitative translation of dog-to-human aging by conserved remodeling of the DNA Methylome. Cell Systems, vol. 11, no. 2, pp. 176–185.e6, 2020/08/26/ 2020, https://doi.org/10.1016/j.cels.2020.06.006.
Lopez-Otin C, Blasco MA, Partridge L, Serrano M, Kroemer G. “The hallmarks of aging,” (in eng). Cell. 2013;153(6):1194–217. https://doi.org/10.1016/j.cell.2013.05.039.
Breeze CE, et al. eFORGE v2.0: updated analysis of cell type-specific signal in epigenomic data. Bioinformatics. 2019;35(22):4767–9. https://doi.org/10.1093/bioinformatics/btz456.
W. Kim et al. ZFP161 regulates replication fork stability and maintenance of genomic stability by recruiting the ATR/ATRIP complex, (in eng), Nat Commun, vol. 10, no. 1, p. 5304, Nov 22 2019, https://doi.org/10.1038/s41467-019-13321-z.
R. Vélez-Cruz and D. G. Johnson. The retinoblastoma (RB) tumor suppressor: pushing back against genome instability on multiple fronts," (in eng), Int J Mol Sci, vol. 18, no. 8, Aug 16 2017, https://doi.org/10.3390/ijms18081776.
Lee M, Rivera-Rivera Y, Moreno CS, Saavedra HI. “The E2F activators control multiple mitotic regulators and maintain genomic integrity through Sgo1 and BubR1,” (in eng). Oncotarget. 2017;8(44):77649–72. https://doi.org/10.18632/oncotarget.20765.
Negrini S, Gorgoulis VG, Halazonetis TD. “Genomic instability–an evolving hallmark of cancer,” (in eng). Nat Rev Mol Cell Biol. 2010;11(3):220–8. https://doi.org/10.1038/nrm2858.
Vijg J, Suh Y. “Genome instability and aging,” (in eng). Annu Rev Physiol. 2013;75:645–68. https://doi.org/10.1146/annurev-physiol-030212-183715.
Morgello S, et al. The National NeuroAIDS Tissue Consortium: a new paradigm in brain banking with an emphasis on infectious disease. Neuropathol Appl Neurobiol. 2001;27(4):326–35.
Horvath S, et al. “Perinatally acquired HIV infection accelerates epigenetic aging in South African adolescents,” (in eng). AIDS (London, England). 2018;32(11):1465–74. https://doi.org/10.1097/QAD.0000000000001854.
Kabacik S, Horvath S, Cohen H, Raj K. “Epigenetic ageing is distinct from senescence-mediated ageing and is not prevented by telomerase expression,” (in eng). Aging (Albany NY). 2018;10(10):2800–15. https://doi.org/10.18632/aging.101588.
A. Arneson et al. A mammalian methylation array for profiling methylation levels at conserved sequences. bioRxiv, p. 2021.01.07.425637, 2021, https://doi.org/10.1101/2021.01.07.425637.
Zhou W, Triche TJ Jr, Laird PW, Shen H. SeSAMe: reducing artifactual detection of DNA methylation by Infinium beadchips in genomic deletions. Nucleic Acids Res. 2018;46(20):e123–e123. https://doi.org/10.1093/nar/gky691.
Friedman J, Hastie T, Tibshirani R. Regularization paths for generalized linear models via coordinate descent. J Stat Softw. 2010;33(1):1–22.
P. Langfelder and S. Horvath. WGCNA: an R package for weighted correlation network analysis," BMC Bioinformatics, vol. 9, no. 1, p. 559, 2008. [Online]. Available: http://www.biomedcentral.com/1471-2105/9/559.
T. L. Bailey et al., "MEME Suite: tools for motif discovery and searching," Nucleic Acids Research, vol. 37, no. suppl_2, pp. W202-W208, 2009, https://doi.org/10.1093/nar/gkp335.
C. Y. McLean et al. GREAT improves functional interpretation of cis-regulatory regions," Nat Biotechnol, vol. 28, 2010// 2010, https://doi.org/10.1038/nbt.1630.
This work was supported by the Paul G. Allen Frontiers Group (SH), National Institute of Aging 1U19AG057758. The additional cat species were graciously provided by White Oak Conservation.
Conflict of interest
SH is a founder of the non-profit Epigenetic Clock Development Foundation which plans to license several patents from his employer UC Regents. These patents list SH as inventor. The other authors declare no conflicts of interest.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Ken Raj and Balazs Szladovits are first joint authors.
Below is the link to the electronic supplementary material.
About this article
Cite this article
Raj, K., Szladovits, B., Haghani, A. et al. Epigenetic clock and methylation studies in cats. GeroScience 43, 2363–2378 (2021). https://doi.org/10.1007/s11357-021-00445-8
- Epigenetic clock
- DNA methylation